Tag:
Generic Pharmaceutical Association
Latest Headlines
Latest Headlines
Generics makers step up for shortages response
The FDA is "not necessarily the best organization to provide notification on shortages," Ralph Neas told Reuters last week, amid a seeming riot of actions and announcements targeting the prevention
UPDATED: Generic drug companies to create private-sector drug shortage warning system
The generic drug industry's major trade group will develop a private-sector system that would warn about medicine shortages, even as the government threatens to step in and officially mandate similar
Longtime liberal advocate to lead generics industry group
The Generic Pharmaceutical Association is about to get a new lead lobbyist: Ralph Neas, whom the New York Times characterizes as "a longtime advocate for liberal causes." Neas told the Times he's
Generic user fees gain traction with Hamburg's backing
It looks as if user fees really are in the offing for generic drugs. After generics makers said last week that they're supporting the idea as a way to speed approvals of their products, FDA
Generics makers aim to forge user-fee agreement
Generic drugmakers are getting their ducks in a row on user fees. At the end of the month, generics firms sit down with FDA to start hammering out a potential user-fee agreement. So, aiming to pick
Generics association scrambles to win back Teva
Generics giant Teva Pharmaceutical Industries ( NASDAQ: TEVA ) simply dwarfs many companies that knock off branded meds. Maybe that's why it's bailing out of the Generic Pharmaceutical Association to
